Mercado Medical Practice/CCT Research
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mercado, Max E
NCT06098079: Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

Recruiting
4
8600
US
Naltrexone-Bupropion (NB) Combination, Placebo
Currax Pharmaceuticals
Obesity
01/29
07/29
NCT06382311: A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

Recruiting
1/2
1080
US
Flu Pandemic mRNA_Dose level 1, Flu Pandemic mRNA_Dose level 2, Flu Pandemic mRNA_ Dose level 3., Flu Pandemic mRNA_ Dose level 4, Flu Pandemic mRNA_Dose level 5, Flu Pandemic mRNA_Dose level 6, Flu Pandemic mRNA_Dose level 7, Placebo
GlaxoSmithKline
Influenza, Human
08/24
05/25
COMPASS, NCT05246839: Informed Choice - Compass

Active, not recruiting
N/A
5280
US
Brief Video, Brief Video Plus
Exact Sciences Corporation, Mayo Clinic, University of Utah, American Cancer Society, Inc., F!ght Colorectal Cancer
Colorectal Cancer
03/29
03/29

Download Options